Bayer to Highlight Additional Analyses From Comprehensive KERENDIA® (finerenone) Clinical Trial Program at the American Society of Nephrology’s 2022 Kidney Week
Neuro Central,
Further post-hoc analysis from FIDELITY, a prespecified, exploratory pooled analysis of FIDELIO-DKD and FIGARO-DKD Phase III…